The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 evaluation of the nilotinib-paclitaxel combination in patients with rare solid tumors: Rapid analysis and response evaluation of combination anti-neoplastic agents in rare tumors trial 1 (RARE CANCER 1).
 
Sarah Shin
No Relationships to Disclose
 
Andre DeSouza
No Relationships to Disclose
 
Jared Foster
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
Geraldine O'Sullivan Coyne
Consulting or Advisory Role - GlaxoSmithKline
Travel, Accommodations, Expenses - Novartis Ireland Ltd.
 
Sarah Miller
No Relationships to Disclose
 
Brooke Augustine
No Relationships to Disclose
 
Mary Jane Ong
No Relationships to Disclose
 
Lamin Juwara
No Relationships to Disclose
 
Jessica Mukherjee
No Relationships to Disclose
 
Ning Ma
No Relationships to Disclose
 
James Doroshow
No Relationships to Disclose
 
Alice Chen
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)